These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16680544)

  • 21. Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial.
    Buck BH; Hill MD; Quinn FR; Butcher KS; Menon BK; Gulamhusein S; Siddiqui M; Coutts SB; Jeerakathil T; Smith EE; Khan K; Barber PA; Jickling G; Reyes L; Save S; Fairall P; Piquette L; Kamal N; Chew DS; Demchuk AM; Shuaib A; Exner DV
    JAMA; 2021 Jun; 325(21):2160-2168. PubMed ID: 34061146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.
    Chew DS; Li Z; Steinberg BA; O'Brien EC; Pritchard J; Bunch TJ; Mark DB; Patel MR; Nabutovsky Y; Greiner MA; Piccini JP
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e010304. PubMed ID: 35089799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device.
    Israel CW; Ehrlich JR; Grönefeld G; Klesius A; Lawo T; Lemke B; Hohnloser SH
    J Am Coll Cardiol; 2001 Aug; 38(2):355-63. PubMed ID: 11499724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
    Healey JS; Wong J
    Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical atrial fibrillation and the risk of stroke.
    Healey JS; Connolly SJ; Gold MR; Israel CW; Van Gelder IC; Capucci A; Lau CP; Fain E; Yang S; Bailleul C; Morillo CA; Carlson M; Themeles E; Kaufman ES; Hohnloser SH;
    N Engl J Med; 2012 Jan; 366(2):120-9. PubMed ID: 22236222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source.
    Ricci B; Chang AD; Hemendinger M; Dakay K; Cutting S; Burton T; Mac Grory B; Narwal P; Song C; Chu A; Mehanna E; McTaggart R; Jayaraman M; Furie K; Yaghi S
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1692-1696. PubMed ID: 29501269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
    Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
    J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend.
    Chamberlain AM; Brown RD; Alonso A; Gersh BJ; Killian JM; Weston SA; Roger VL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack.
    Jabaudon D; Sztajzel J; Sievert K; Landis T; Sztajzel R
    Stroke; 2004 Jul; 35(7):1647-51. PubMed ID: 15155965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial lead implantation during atrial flutter or fibrillation?
    Kindermann M; Fröhlig G; Berg M; Lawall P; Schieffer H
    Pacing Clin Electrophysiol; 1998 Aug; 21(8):1531-8. PubMed ID: 9725150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
    Lopes RD; Alings M; Connolly SJ; Beresh H; Granger CB; Mazuecos JB; Boriani G; Nielsen JC; Conen D; Hohnloser SH; Mairesse GH; Mabo P; Camm AJ; Healey JS
    Am Heart J; 2017 Jul; 189():137-145. PubMed ID: 28625370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.